Strategic Partner
Doctolib
A strategic partner of Cadmus Investment Management — one of the relationships through which the firm sources, assesses, and supports opportunities in its chosen sectors.
A strategic partner of Cadmus Investment Management — one of the relationships through which the firm sources, assesses, and supports opportunities in its chosen sectors.
Doctolib is a French digital-health company that has become one of Europe's largest e-health platforms. It connects patients with practitioners through online appointment booking and provides practice-management software to healthcare professionals, operating across France, Germany, and Italy. In doing so it has embedded itself in the daily workflow of a very large number of doctors and the care journeys of millions of patients.
The strategic significance of Doctolib is its position at the centre of the care relationship in three of Europe's largest healthcare markets. Health systems are notoriously difficult to enter — fragmented, heavily regulated, and slow to adopt — and Doctolib has earned trusted access to both sides of the encounter. That distribution, built patiently and to a high standard of data protection, is the asset that makes it a valuable partner.
Doctolib opens access to digital health and healthtech — a sector where the potential is enormous but the barriers are unusually high. Clinical adoption is cautious, data protection is stringent, and reimbursement structures vary by country. Success depends less on technical brilliance than on the credibility and reach to get a product into genuine clinical use.
Through Doctolib, Cadmus Investment Management can approach that sector with a partner whose footprint across three major European markets shortens the hardest part of the journey. A health-technology opportunity can be judged against the reality of a platform already operating inside European healthcare, turning a sector that defeats many good products into one where adoption becomes a solvable problem.
The most promising co-investment opportunities alongside Doctolib sit in health software and clinical workflow, telemedicine, patient-data infrastructure, and the practice-management tools that keep providers running.
In each of these, Doctolib's footprint accelerates adoption. A telemedicine service, a workflow tool, or a patient-data business gains what it most needs and can least easily obtain — a route into real clinical settings across several countries, with the trust and the data-protection standards that healthcare demands already established.
Cadmus Investment Management brings the patient capital and long horizon that healthcare businesses require, given their slow and evidence-driven adoption cycles. Pairing a trusted platform with a disciplined investor lets a promising company build the clinical evidence and operational depth durable health businesses are made of, without being rushed by a short-horizon owner.